Back | Next |
home / stock / amrn / amrn message board
Subject | By | Source | When |
---|---|---|---|
It's still my honest opinion that Sarissa is | JRoon71 | investorshub | 07/19/2024 6:34:26 PM |
JRoon If the buy back is in play we | hayward | investorshub | 07/19/2024 6:31:58 PM |
IMO Amarin hasn't purchased any shares to try | Mr Stockboy | investorshub | 07/19/2024 6:13:04 PM |
https://www.investopedia.com/terms/s/sharerepurchase.asp#:~:text=Because%20a%20s | Number sleven | investorshub | 07/19/2024 6:01:40 PM |
Ram, I'm not sure. I don't know if | JRoon71 | investorshub | 07/19/2024 5:44:06 PM |
I have no idea how these things work | ramfan60 | investorshub | 07/19/2024 5:28:51 PM |
They avoid the blackout period by establishing the | JRoon71 | investorshub | 07/19/2024 5:13:10 PM |
I totally agree on the knowing part .. | Denisk | investorshub | 07/19/2024 5:03:35 PM |
Good question. I'm not sure of the timing, | JRoon71 | investorshub | 07/19/2024 4:48:12 PM |
Well most of the higher trading volume took | Denisk | investorshub | 07/19/2024 4:05:50 PM |
Well, if they've been buying prior to June | JRoon71 | investorshub | 07/19/2024 3:42:41 PM |
If they mention anything at all about the | Denisk | investorshub | 07/19/2024 3:21:54 PM |
https://www.courtlistener.com/docket/59859757/dr-reddys-laboratories-inc-v-amari | Number sleven | investorshub | 07/19/2024 3:20:35 PM |
This is a great study! Thanks for sharing | JRoon71 | investorshub | 07/19/2024 3:01:34 PM |
MRM, not so sure. Keep in mind they | JRoon71 | investorshub | 07/19/2024 2:59:13 PM |
This volume does not look like the buy | mrmainstreet | investorshub | 07/19/2024 2:28:21 PM |
https://x.com/JAHA AHA/status/1813745843146571976 | DMC8 | investorshub | 07/19/2024 12:31:53 PM |
Gleaned so much from our board today. I | The Canes | investorshub | 07/19/2024 11:43:06 AM |
Nuke, I understand. The primary topic of discussion | Number sleven | investorshub | 07/19/2024 8:46:31 AM |
N7, but it effects everything we do. We're | Nukemtiltheyglow | investorshub | 07/19/2024 2:17:08 AM |
News, Short Squeeze, Breakout and More Instantly...
Amarin Corporation plc Company Name:
AMRN Stock Symbol:
NASDAQ Market:
Amarin Corporation plc Website:
-- Portuguese Ministry of Health approves VAZKEPA® (icosapent ethyl) for national reimbursement to reduce the risk of cardiovascular (CV) events in patients with established cardiovascular disease (CVD) 1 -- -- Approval marks eighth national reimbursement of VAZKEPA®...
DUBLIN and BRIDGEWATER, N.J., July 17, 2024 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that it will host a conference call with Aaron Berg, President & CEO, and members of Amarin’s senior management team to discuss its second quarter 2024 results followed ...
-- VASCEPA Approved by the National Medical Products Administration (NMPA) To Reduce the Risk of Cardiovascular Events as an Adjunct to Statin Therapy in Adult Patients with Elevated Triglyceride (TG) Levels (≥150 mg/dL) and Other High-Risk Characteristics as Studied in REDUCE-IT -- ...